PMID- 9692908 OWN - NLM STAT- MEDLINE DCOM- 19980824 LR - 20190620 IS - 0014-2956 (Print) IS - 0014-2956 (Linking) VI - 255 IP - 1 DP - 1998 Jul 1 TI - Disulphide bonds assignment in the inter-alpha-inhibitor heavy chains--structural and functional implications. PG - 107-15 AB - Human inter-alpha-inhibitor (IalphaI) is a plasma serine-proteinase inhibitor. It consists of three polypeptide chains covalently linked by a glycosaminoglycan: a light one named bikunin, carrying the antiproteinase activity and two heavy chains H1 and H2. The amino acid sequences of these heavy chains are highly similar; however when IalphaI is digested by neutrophil proteinases, their proteolytic susceptibility strongly differs [Balduyck, M., Piva, F., Mizon, C., Maes, P., Malki, N., Gressier, B., Michalski, C. & Mizon, J. (1993) Human leucocyte elastase (HLE) preferentially cleaves the heavy chain H2 of inter-alpha-trypsin inhibitor (ITI), Biol. Chem. Hoppe-Seyler 374, 895-901]. We mapped the disulphide topology of the IalphaI heavy chains in order to investigate whether or not disulphide bonds might be responsible for their differential susceptibility to proteolysis. Using amino acid sequencing and mass spectrometry analysis, we demonstrate that the H1 heavy chain contains one free thiol group and two disulphide bridges of which one links two largely spaced cysteine residues (Cys239 and Cys511). Thus H1 is clearly different from H2 which contains two disulphide bonds between closely located cysteine residues. However, using immunoprint analysis, we show that, when IalphaI is subjected to a limited digestion by Staphylococcus aureus V-8 proteinase, the two polypeptide chains are similarly susceptible to proteolysis. This enzyme preferentially cleaves the IalphaI heavy chains from their N-terminal extremity. These results are consistent with the circular dichroism (CD) analysis, suggesting that the conformation of the polypeptide backbone of H1 is not very different from that of H2, with calculated alpha-helicities of 24% and 28%, respectively. The CD measurements reveal that the aromatic amino acids of H1 and H2 are in a different asymmetrical environment. Inside the IalphaI molecule, the heavy chains are linked to the glycosaminoglycan chain via their C-terminal aspartic acid residue. Thus we suggest that the affinity of cationic neutrophil proteinases for the anionic glycosaminoglycan is responsible for the cleavage of the heavy chains (mainly H2) near their C-terminal end and the high susceptibility of IalphaI to these proteinases. FAU - Flahaut, C AU - Flahaut C AD - Laboratoire de Biochimie, Faculte de Pharmacie, Lille, France. FAU - Mizon, C AU - Mizon C FAU - Aumercier-Maes, P AU - Aumercier-Maes P FAU - Colson, P AU - Colson P FAU - Bailly, C AU - Bailly C FAU - Sautiere, P AU - Sautiere P FAU - Mizon, J AU - Mizon J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Eur J Biochem JT - European journal of biochemistry JID - 0107600 RN - 0 (Alpha-Globulins) RN - 0 (Blood Proteins) RN - 0 (Disulfides) RN - 0 (Peptide Fragments) RN - 0 (Serine Proteinase Inhibitors) RN - 39346-44-6 (inter-alpha-inhibitor) RN - EC 3.4.- (Cathepsins) RN - EC 3.4.- (Endopeptidases) RN - EC 3.4.21.- (Serine Endopeptidases) RN - EC 3.4.21.19 (glutamyl endopeptidase) RN - EC 3.4.21.20 (CTSG protein, human) RN - EC 3.4.21.20 (Cathepsin G) RN - EC 3.4.21.37 (Leukocyte Elastase) RN - EC 3.4.24.- (Metalloendopeptidases) RN - EC 3.4.24.20 (peptidyl-Lys metalloendopeptidase) RN - OS382OHJ8P (Cyanogen Bromide) SB - IM MH - Alpha-Globulins/*chemistry/metabolism MH - Amino Acid Sequence MH - Blood Proteins/*chemistry/metabolism MH - Cathepsin G MH - Cathepsins/metabolism MH - Circular Dichroism MH - Cyanogen Bromide MH - Disulfides/*chemistry/metabolism MH - Endopeptidases/*metabolism MH - Humans MH - Leukocyte Elastase/metabolism MH - Metalloendopeptidases/metabolism MH - Molecular Sequence Data MH - Peptide Fragments/chemistry MH - Sequence Analysis MH - Serine Endopeptidases/metabolism MH - Serine Proteinase Inhibitors/*chemistry/metabolism EDAT- 1998/08/06 00:00 MHDA- 1998/08/06 00:01 CRDT- 1998/08/06 00:00 PHST- 1998/08/06 00:00 [pubmed] PHST- 1998/08/06 00:01 [medline] PHST- 1998/08/06 00:00 [entrez] AID - 10.1046/j.1432-1327.1998.2550107.x [doi] PST - ppublish SO - Eur J Biochem. 1998 Jul 1;255(1):107-15. doi: 10.1046/j.1432-1327.1998.2550107.x.